華安鑫創(300928.SZ):獲得客户項目定點通知
格隆匯8月1日丨華安鑫創(300928.SZ)公佈,公司自2024年4月19日至公吿披露日合計收到項目定點通知9個,預計項目週期為2.5-5年不等。其中,在智能座艙終端市場拓展方面,公司收到了來自長安汽車、奇瑞汽車及中興汽車的定點通知,確認公司為其銷售範圍為全球市場的主要車型提供顯示系統終端或主機控制系統產品開發及配套,同時,亞洲某頭部飛行汽車製造商也確認公司取得其低空飛行器的座艙顯示系統終端等產品開發及供貨資格。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.